Table: Hisamitsu - 6-MTH group results
Oct 12 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Aug 31, 2022 Aug 31, 2021 Feb 28, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 59.62 58.55 123.00
(+1.8 pct) (+10.6 pct) (+2.3 pct)
Operating 4.91 5.71 11.10
(-13.9 pct) (+3.5 pct) (+18.9 pct)
Recurring 8.87 6.84 12.70
(+29.7 pct) (+23.9 pct) (+0.5 pct)
Net 6.50 5.00 9.70
(+30.0 pct) (+35.4 pct) (+0.4 pct)
EPS 81.58 yen 61.20 yen 121.64 yen
EPS Diluted 81.51 yen 61.16 yen
Ann Div 84.00 yen 84.50 yen
-Q2 div 42.25 yen 42.00 yen
-Q4 div 42.00 yen 42.25 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO